Skip to content
healthcare.dev

Cyclobenzaprine Hydrochloride

NDC 0115-1437, Cyclobenzaprine Hydrochloride, capsule, extended release, from Amneal Pharmaceuticals of New York LLC.

Product NDC
0115-1437
Status
Listed
Labeler
Amneal Pharmaceuticals of New York LLC
Dosage form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA AUTHORIZED GENERIC
Application
NDA021777
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1437 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYCLOBENZAPRINE HYDROCHLORIDE30 mg/1

Pharmacologic classes

Centrally-mediated Muscle Relaxation [PE]; Muscle Relaxant [EPC]

Package NDCNDC-11Package
0115-1437-130011514371360 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0115-1437-13)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/dd546a0e-e5be-4232-8ad8-fcd7d5f9a903
  • NADAC price for package 00115143713

    GET /v1/drugs/nadac/00115143713

Use it

Look up 0115-1437 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0115-1437 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0115-1437. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.